Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software

NCT ID: NCT03001154

Last Updated: 2019-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale implementation of this promising treatment. The present study will investigate whether off-the-shelf, commercial VR hardware and software can be used as stimuli material to conduct in-session exposure therapy for speech anxiety. The study will recruit n=25+25 participants from the general public suffering from substantial speech anxiety, who will be randomized to either a waiting-list, or one-session VRET with a therapist, followed by four weeks of a progressive maintenance program encouraging in-vivo exposure. The waiting-list group will then receive an Internet-delivered VRET treatment program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Phobia Anxiety Behavior Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

One-session VRET face-to-face

One-session Virtual Reality Exposure Therapy led by therapist (face-to-face), followed by a 4-week therapist-guided Internet-administered progressive maintenance program.

Group Type EXPERIMENTAL

Face-to-face Virtual Reality Exposure Therapy

Intervention Type BEHAVIORAL

In session, systematic, hierarchical exposure to feared stimuli with therapist.

Waiting-list, then Internet-administered VRET

4-week waiting list, followed by therapist-guided, Internet-administered VRET with a 4-week progressive maintenance program.

Group Type EXPERIMENTAL

Internet-administered Virtual Reality Exposure Therapy

Intervention Type BEHAVIORAL

Therapist-guided, Internet-administered Virtual Reality Exposure Therapy self-help program

Waiting-list

Intervention Type OTHER

Weekly assessments of public speaking

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Face-to-face Virtual Reality Exposure Therapy

In session, systematic, hierarchical exposure to feared stimuli with therapist.

Intervention Type BEHAVIORAL

Internet-administered Virtual Reality Exposure Therapy

Therapist-guided, Internet-administered Virtual Reality Exposure Therapy self-help program

Intervention Type BEHAVIORAL

Waiting-list

Weekly assessments of public speaking

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Substantial public speaking anxiety
* Have access to VR-compatible smartphone (including Internet)
* Can travel to Stockholm University for treatment on one occasion
* Can speak and understand sufficient Swedish

Exclusion Criteria

* Deficits in sight or balance impacting the VR-experience
* A severe psychiatric disorder better treated elsewhere, including current major depression, alcohol or drug abuse, bipolarity, psychosis or similar
* Active psychopharmacological treatment, unless stable for last 3 months
* Other ongoing psychological treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stockholm University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Per Carlbring

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychology

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VRetorik

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual Reality for Youth Phobias
NCT05839431 COMPLETED NA